The Community Programs F_AO1_R Clinical Research AA1_N AIDS    CPCRA    W_AA1_Z AH0 P_R_OW1_G_R_AE2_M S_P_AA1_N_S_ER0_D B_AY1 National Institutes AH1_V Health    NIH    IH0_N DH_AH0 United States     It B_IH0_G_AE1_N IH0_N 1989    AH0_N_D W_AA1_Z IH2_N_S_T_R_AH0_M_EH1_N_T_AH0_L IH0_N S_AH1_M R_IY0_S_ER1_CH D_EY1_T_AH0_B_EY2_S_IH0_Z B_IY1_IH0_NG IH0_S_T_AE1_B_L_IH0_SH_T Research F_R_AH1_M DH_AH0 P_R_OW1_G_R_AE2_M_Z AH0_S_IH1_S_T_AH0_D DH_AH0 IH0_V_AE2_L_Y_UW0_EY1_SH_AH0_N AH1_V TH_EH1_R_AH0_P_IY0_Z F_AO1_R HIV IH0_N D_AY0_V_ER1_S P_AA2_P_Y_AH0_L_EY1_SH_AH0_N_Z The CPCRA W_AA1_Z IH0_S_T_AE1_B_L_IH0_SH_T IH0_N 1989    AH0_N_D IH2_N_K_L_UW1_D_AH0_D 15 R_IY0_S_ER1_CH Y_UW1_N_AH0_T_S Statistical Center AE1_T DH_AH0 University AH1_V Minnesota W_AA1_Z F_AH1_N_D_AH0_D F_R_AH1_M 1990 T_UW1 1997     The CPCRA W_AA1_Z W_AH1_N AH1_V F_AO1_R N_EH1_T_W_ER2_K_S DH_AE1_T NIH W_AA1_Z Y_UW1_Z_IH0_NG T_UW1 K_AA1_N_D_AH0_K_T K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z DH_AE1_T W_ER1 L_UH1_K_IH0_NG T_UW1 AH2_N_D_ER0_S_T_AE1_N_D P_AA1_S_AH0_B_AH0_L TH_EH1_R_AH0_P_IY0_Z F_AO1_R P_IY1_P_AH0_L W_IH1_DH HIV IH2_N_F_EH1_K_SH_AH0_N    Th CPCRA N_EH1_T_W_ER2_K W_AA1_Z K_AH0_M_Y_UW1_N_AH0_T_IY0 B_EY1_S_T W_IH1_DH AE1_K_S_EH2_S T_UW1 D_AY0_V_ER1_S P_AA2_P_Y_AH0_L_EY1_SH_AH0_N_Z AH0_K_R_AO1_S DH_AH0 S_P_EH1_K_T_R_AH0_M AH1_V HIV D_IH0_Z_IY1_Z_AH0_Z     The OW1_V_ER0_AO2_L AH0_B_JH_EH1_K_T_IH0_V AH1_V DH_AH0 CPCRA IH1_Z T_UW1 D_IH0_Z_AY1_N S_T_AH1_D_IY0_Z AH1_V S_AH0_F_IH1_SH_AH0_N_T S_AY1_Z AH0_N_D D_UH1_R_EY1_SH_AH0_N AH1_V F_AA1_L_OW0 AH1_P T_UW1 IH0_V_AE1_L_Y_UW0_EY2_T DH_AH0 L_AO1_NG T_ER1_M B_EH1_N_AH0_F_IH0_T_S AH0_N_D AH2_N_IH0_N_T_EH1_N_D_IH0_D K_AA1_N_S_AH0_K_W_EH2_N_S_AH0_Z AH1_V V_EH1_R_IY0_AH0_S T_R_IY1_T_M_AH0_N_T S_T_R_AE1_T_AH0_JH_IY0_Z Y_UW1_Z_IH0_NG AH0_V_EY1_L_AH0_B_AH0_L EY1_JH_AH0_N_T_S T_UW1 AH0_S_EH1_S L_AO1_NG T_ER1_M immunologic    virologic AH0_N_D K_L_IH1_N_AH0_K_AH0_L AW1_T_K_AH2_M_Z CPCRA T_R_AY1_AH0_L_Z AA1_R D_IH0_Z_AY1_N_D W_IH1_DH N_EH1_S_T_AH0_D substudies EY1_M_D AE1_T AH2_N_D_ER0_S_T_AE1_N_D_IH0_NG DH_AH0 pathogenesis AH1_V HIV IH2_N_F_EH1_K_SH_AH0_N AH0_N_D DH_AH0 P_AH1_B_L_IH0_K HH_EH1_L_TH IH2_M_P_L_AH0_K_EY1_SH_AH0_N_Z AH1_V IH1_T_S T_R_IY1_T_M_AH0_N_T    By 2001    CPCRA HH_AE1_D 244 P_IY1_P_AH0_L P_AA0_R_T_IH1_S_AH0_P_EY2_T_IH0_NG IH0_N DH_EH1_R S_T_AH1_D_IY0_Z    W_IH1_DH T_R_AY1_AH0_L_Z AH2_N_D_ER0_W_EY1 IH0_N 17 S_IH1_T_IY0_Z    The International Network F_AO1_R Strategic Initiatives IH0_N Global HIV Trials    INSIGHT    biorepository S_IH1_S_T_AH0_M HH_AE1_Z IH1_T_S R_UW1_T_S IH0_N DH_AH0 CPCRA    An antiretroviral M_EH2_D_AH0_K_EY1_SH_AH0_N S_EH1_L_F R_IY0_P_AO1_R_T_IH0_NG K_W_EH2_S_CH_AH0_N_EH1_R W_AA1_Z D_IH0_V_EH1_L_AH0_P_T B_AY1 DH_AH0 P_R_OW1_G_R_AE2_M    The P_R_OW1_G_R_AE2_M organised DH_AH0 058 FIRST    Flexible Initial Retrovirus Suppressive Therapies    T_R_AY1_AH0_L    AH0 L_AA1_R_JH    L_AO1_NG T_ER1_M    R_AE1_N_D_AH0_M_AY2_Z_D    P_R_AH0_S_P_EH1_K_T_IH0_V K_AH0_M_P_EH1_R_AH0_S_AH0_N AH1_V TH_R_IY1 D_IH1_F_ER0_AH0_N_T antiretroviral S_T_R_AE1_T_AH0_JH_IY0_Z IH0_N HH_AY1_L_IY0 AE1_K_T_IH0_V antiretroviral TH_EH1_R_AH0_P_IY0 N_AA1 V_IY1    HIV IH2_N_F_EH1_K_T_IH0_D P_ER1_S_AH0_N_Z    